CompletedNCT01429454
Omega-3 or Placebo for Young People at Risk of Psychosis
About this title
Read the official source — NCT01429454Medication studyAges 12–30United States + CanadaSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 12 years to 30 years.
- Listed locations
- Los Angeles and 8 more locationsSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: August 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 127
- Sponsor
- University of California, San Diego
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States, Canada
- Age range
- From 12 Years to 30 Years
- Official registry ID
- NCT01429454
- Official title
Show the full official title
Randomized Double-Blind Trial of Omega 3 Fatty Acid Versus Placebo in Individuals at Risk for Psychosis
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles, United States · San Diego, United States · New Haven, United States
6 more locations
- Atlanta, United States
- Boston, United States
- Glen Oaks, United States
- Chapel Hill, United States
- Pittsburgh, United States
- Calgary, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Diego, a university.
Did this study involve medication?
Yes. The study involved medication, including Omega-3 Long Chain Fatty Acid and Placebo.
Who was this study for?
Listed age limits: 12 years to 30 years.
